Skip to main content
. 2022 Apr 28;10(4):363–375. doi: 10.1002/ueg2.12227

TABLE 1.

Participant characteristics

All patients n = 103 Intervention n = 78 Control n = 25 p
Age, years 46 (33–57) 48 (37–57) 35 (29–50) 0.028
BMI, kg/m2 24.2 (22.3–27.6) 24.6 (22.3–28.4) 23.6 (21.4–26.5) 0.180
Missing value: 6
Weight, kg 71 (63–82) 72 (64–84) 68 (57–75) 0.037
Missing value: 6
Female sex, n (%) 81 (78.6) 59 (75.6) 22 (88.0) 0.265
Smoker, n (%) 11 (11.0) 5 (6.6) 6 (24.0) 0.033
Missing value: 3
Disease duration, years 17 (8.8–28) 18 (8.0–28) 11 (9.0–29) 0.561
Missing value: 17
Employment, n (%) 0.049
Missing value: 2
100% 51 (50.5) 43 (56.6) 8 (32.0)
≥50% 64 (63.4) 52 (68.4) 12 (48.0)
Subgroup, n (%) 0.227
Missing value: 2
IBS‐D 26 (25.2) 23 (29.5) 3 (12.0)
IBS‐M 37 (35.9) 29 (37.2) 8 (32.0)
IBS‐C 19 (18.4) 12 (15.4) 7 (28.0)
Unspecified IBS 3 (2.9) 2 (2.6) 1 (4.0)
Non‐IBS FGID 16 (15.6) 10 (12.8) 6 (24.0)
Physical activity, n (%) 0.863
Missing value: 2
None 11 (10.9) 9 (11.8) 2 (8.0)
<30 min/week 24 (23.8) 19 (25.0) 5 (20.0)
30–60 min/week 15 (14.6) 11 (14.5) 4 (16.0)
60–120 min/week 25 (24.8) 19 (25.0) 6 (24.0)
>120 min/week 26 (25.7) 18 (23.7) 8 (32.0)
Antibiotic use, n (%)
0–6 months before study 15 (14.9) 11 (14.5) 4 (16.0) 1.0
Missing value: 2
During study 4 (4.3) 3 (4.2) 1 (4.8) 0.925
Missing value: 10

Abbreviations: BMI, body mass index; FGID, functional gastrointestinal disorders; IBS, irritable bowel syndrome; IBS‐D, diarrhea‐predominant irritable bowel syndrome; IBS‐M, mixed IBS; IBS‐C, constipation‐predominant IBS.

Note: Values are presented as median and interquartile ranges (IQR) or number and percentage. Mann–Whitney U test or Fisher's exact test. p < 0.05 was considered statistically significant.